Your browser doesn't support javascript.
loading
Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study.
Wen, Feng; Zheng, Hanrui; Zhang, Pengfei; Zhou, Jing; Chen, Hongdou; Zhou, Kexun; Li, Qiu; Bi, Feng.
Affiliation
  • Wen F; Department of Medical Oncology, West China Hospital, Sichuan University, Sichuan, China.
  • Zheng H; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, Sichuan, China.
  • Zhang P; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, Sichuan, China.
  • Zhou J; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Sichuan, China.
  • Chen H; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, Sichuan, China.
  • Zhou K; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Sichuan, China.
  • Li Q; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, Sichuan, China.
  • Bi F; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Sichuan, China.
Eur J Cancer Care (Engl) ; 29(1): e13196, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31825141

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Camptothecin / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Eur J Cancer Care (Engl) Year: 2020 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Camptothecin / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Eur J Cancer Care (Engl) Year: 2020 Type: Article Affiliation country: China